230 related articles for article (PubMed ID: 24388862)
41. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.
Boyd KA; Briggs AH
Addiction; 2009 Feb; 104(2):317-25. PubMed ID: 19149829
[TBL] [Abstract][Full Text] [Related]
42. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
Bertram MY; Lim SS; Wallace AL; Vos T
Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
[TBL] [Abstract][Full Text] [Related]
43. Age and educational inequalities in smoking cessation due to three population-level tobacco control interventions: findings from the International Tobacco Control (ITC) Netherlands Survey.
Nagelhout GE; Crone MR; van den Putte B; Willemsen MC; Fong GT; de Vries H
Health Educ Res; 2013 Feb; 28(1):83-91. PubMed ID: 23087009
[TBL] [Abstract][Full Text] [Related]
44. Are lower income smokers more price sensitive?: the evidence from Korean cigarette tax increases.
Choi SE
Tob Control; 2016 Mar; 25(2):141-6. PubMed ID: 25430738
[TBL] [Abstract][Full Text] [Related]
45. A cost-effectiveness analysis of the first federally funded antismoking campaign.
Xu X; Alexander RL; Simpson SA; Goates S; Nonnemaker JM; Davis KC; McAfee T
Am J Prev Med; 2015 Mar; 48(3):318-25. PubMed ID: 25498550
[TBL] [Abstract][Full Text] [Related]
46. Economic Evaluation of Five Tobacco Control Policies Across Seven European Countries.
Leão T; Perelman J; Clancy L; Mlinarić M; Kinnunen JM; Nuyts PAW; Mélard N; Rimpelä A; Lorant V; Kunst AE
Nicotine Tob Res; 2020 Jun; 22(7):1202-1209. PubMed ID: 31350556
[TBL] [Abstract][Full Text] [Related]
47. Equity impact of population-level interventions and policies to reduce smoking in adults: a systematic review.
Brown T; Platt S; Amos A
Drug Alcohol Depend; 2014 May; 138():7-16. PubMed ID: 24674707
[TBL] [Abstract][Full Text] [Related]
48. Effects of a workplace-smoking ban in combination with tax increases on smoking in the Dutch population.
Verdonk-Kleinjan WM; Candel MJ; Knibbe RA; Willemsen MC; de Vries H
Nicotine Tob Res; 2011 Jun; 13(6):412-8. PubMed ID: 21357728
[TBL] [Abstract][Full Text] [Related]
49. Socio-economic status in relation to smoking: The role of (expected and desired) social support and quitter identity.
Meijer E; Gebhardt WA; Van Laar C; Kawous R; Beijk SC
Soc Sci Med; 2016 Aug; 162():41-9. PubMed ID: 27328056
[TBL] [Abstract][Full Text] [Related]
50. Modelling the implications of regular increases in tobacco taxation in the tobacco endgame.
Cobiac LJ; Ikeda T; Nghiem N; Blakely T; Wilson N
Tob Control; 2015 Jun; 24(e2):e154-60. PubMed ID: 25145342
[TBL] [Abstract][Full Text] [Related]
51. Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease.
Berndt N; Bolman C; Lechner L; Max W; Mudde A; de Vries H; Evers S
Eur J Health Econ; 2016 Apr; 17(3):269-85. PubMed ID: 25796578
[TBL] [Abstract][Full Text] [Related]
52. Reducing the burden of smoking world-wide: effectiveness of interventions and their coverage.
Jha P; Chaloupka FJ; Corrao M; Jacob B
Drug Alcohol Rev; 2006 Nov; 25(6):597-609. PubMed ID: 17132576
[TBL] [Abstract][Full Text] [Related]
53. Public attitudes towards healthcare policies promoting tobacco cessation in Germany: results from the representative German study on tobacco use (DEBRA study).
Kastaun S; Kotz D; Brown J; Shahab L; Boeckmann M
BMJ Open; 2019 Aug; 9(8):e026245. PubMed ID: 31462463
[TBL] [Abstract][Full Text] [Related]
54. The cost-effectiveness of call-back counselling for smoking cessation.
Lal A; Mihalopoulos C; Wallace A; Vos T
Tob Control; 2014 Sep; 23(5):437-42. PubMed ID: 23748188
[TBL] [Abstract][Full Text] [Related]
55. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
Bolin K; Lindgren B; Willers S
Chest; 2006 Mar; 129(3):651-60. PubMed ID: 16537864
[TBL] [Abstract][Full Text] [Related]
56. Use of smoking cessation and quit support services by socioeconomic status over 10 years of the national drug strategy household survey.
Clare P; Slade T; Courtney RJ; Martire KA; Mattick RP
Nicotine Tob Res; 2014 Dec; 16(12):1647-55. PubMed ID: 25320110
[TBL] [Abstract][Full Text] [Related]
57. Community-based youth tobacco control interventions: cost effectiveness of the Full Court Press project.
Ross H; Powell LM; Bauer JE; Levy DT; Peck RM; Lee HR
Appl Health Econ Health Policy; 2006; 5(3):167-76. PubMed ID: 17132031
[TBL] [Abstract][Full Text] [Related]
58. Cost effectiveness of full coverage of the medical management of smoking cessation in France.
Chevreul K; Cadier B; Durand-Zaleski I; Chan E; Thomas D
Tob Control; 2014 May; 23(3):223-30. PubMed ID: 23197369
[TBL] [Abstract][Full Text] [Related]
59. Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience.
Croghan IT; Offord KP; Evans RW; Schmidt S; Gomez-Dahl LC; Schroeder DR; Patten CA; Hurt RD
Mayo Clin Proc; 1997 Oct; 72(10):917-24. PubMed ID: 9379693
[TBL] [Abstract][Full Text] [Related]
60. Impact of tobacco control interventions on socioeconomic inequalities in smoking: review of the evidence.
Hill S; Amos A; Clifford D; Platt S
Tob Control; 2014 Nov; 23(e2):e89-97. PubMed ID: 24046211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
